Results 231 to 240 of about 8,764,812 (280)

Hacking Performance Studies

open access: yesGlobal Performance Studies, 2017
openaire   +1 more source

Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib

open access: yesMolecular Oncology, EarlyView.
WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute   +17 more
wiley   +1 more source

Variation in Variation Measurement: A Mapping Review of Methods to Study Clinical Variation. [PDF]

open access: yesJ Eval Clin Pract
Quinn AE   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy